Abstract |
Treatment modalities for resistant/relapsing gastric mucosa associated lymphoid tissue (MALT) non-Hodgkin's lymphoma (NHL) are not yet well standardized. In the past, most patients were treated surgically with a gastrectomy, while, more recently, radiotherapy and systemic approaches ( chemotherapy and immunotherapy) have been used with improving results.Here, we report the case of a patient affected by MALT NHL resistant to antibiotics, chemotherapy and immunotherapy, who achieved a durable complete remission after radio- immunotherapy treatment with Zevalin ((90)Y ibritumomab-tiuxetan), administered in a single-standard dose. This observation must be confirmed on a larger series but suggests that radio- immunotherapy may be a valid approach in treating relapsing MALT NHL patients, or those resistant to conventional therapies, so avoiding more aggressive and toxic approaches.
|
Authors | P F Ferrucci, A Vanazzi, C Crosta, G Pruneri, C Grana, M Bartolomei, G Paganelli, G Martinelli |
Journal | Ecancermedicalscience
(Ecancermedicalscience)
Vol. 2
Pg. 79
( 2008)
ISSN: 1754-6605 [Print] England |
PMID | 22275968
(Publication Type: Case Reports)
|